Viewing Study NCT01278758


Ignite Creation Date: 2025-12-25 @ 12:09 AM
Ignite Modification Date: 2025-12-25 @ 10:09 PM
Study NCT ID: NCT01278758
Status: TERMINATED
Last Update Posted: 2020-12-09
First Post: 2011-01-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module